Oramed technology patented with World Intellectual Property Organization

By Elaine Rigoli

Tampa, Fla., Sept. 13 - Oramed Pharmaceuticals, Inc. said the application of a patent cooperation treaty for the methods and compositions for oral administration of proteins has been approved and filed with World Intellectual Property Organization.

The company said priority was claimed from 60/713,716, all countries were designated and the U.S. Patent and Trademark Office was designated as Search and Examination Authority.

The Jerusalem, Israel-based pharmaceutical company said this is expected to ensure global patent protection for Oramed's proprietary technology to deliver insulin orally.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.